Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort ascending	PI Organization	Title	Grant Number	Initiative	Program Official
Guo, Xingyi	Vanderbilt University Medical Center United States	Leveraging Omics and Electronic Health Records Data to study Colorectal Adenoma genetics and Drug Repurposing	1R01CA297582-01A1		Gary Della'Zanna, D.O., M.Sc.
Gudas, Lorraine J	Weill Medical Coll Of Cornell Univ United States	CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention	5R01CA270248-03		Anda Vlad, M.D., Ph.D.
Grossman, Douglas	Utah State Higher Education System--University Of Utah United States	Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma	5R21CA289101-02		Nicholas Hodges, Ph.D.
Gross, Howard M	Dayton Clinical Oncology Program United States	Dayton Clinical Oncology Program	3UG1CA189957-11S1		Vanessa A. White, M.P.H.
Groninger, J. Hunter	Medstar Health Research Institute United States	Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing	1R21CA299799-01		Brennan Streck, Ph.D., RN, M.P.H.
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules	5R01CA252964-05		Claire Zhu, Ph.D.
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer	4U01CA152662-14		Guillermo Marquez, Ph.D.
Grimm, Lars J	Duke University United States	Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications	4R01CA271237-04	PAR-19-264 (R01 Clinical Trial Optional)	Guillermo Marquez, Ph.D.
Greene, Nicholas Perry	University Of Arkansas At Fayetteville United States	DEVELOPMENT OF TARGETED APPROACHES IN PREVENTION OF CANCER-CACHEXIA	5R01AR075794-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus	5U2CCA271902-04		Matthew Young, Ph.D.